| Momentum Bucket | Strong Momentum |
| Legal Title | AN ACT Relating to anaphylaxis medications in schools; |
| Bill Description | Concerning anaphylaxis medications in schools. |
|
What this bill does
Powered by Legitron |
This bill amends existing law (RCW 28A.210.383 and RCW 28A.210.380) to allow school districts and private schools, including charter schools and state‑tribal compact schools, to maintain a designated supply of epinephrine (including autoinjectors) sized to school enrollment. A licensed prescriber may write prescriptions in the school’s name accompanied by a standing order for administration of school‑supplied, undesignated epinephrine. Donations of epinephrine are permitted if accompanied by a prescription. School nurses and other designated, trained school personnel may use school‑owned epinephrine or any available epinephrine on school property or during sanctioned trips to respond to an anaphylactic reaction, and school nurses or designated personnel may carry school‑owned epinephrine on field trips. If epinephrine that is not school‑owned and not owned by the recipient is administered, the school must reimburse the owner for the cost.
The bill changes procedures and creates liability and personnel protections: prescribers and pharmacists who provide epinephrine to a school are not liable for injuries from its administration unless they acted with conscious disregard for safety; school employees and related school entities are not criminally or civilly liable for administering epinephrine when acting in substantial compliance with a student’s prescription or with written school policies aligned with the standing protocol under RCW 28A.210.380. Employees (except those licensed under chapter 18.79 RCW) who have not agreed in writing to administer autoinjectors may file a written refusal and such refusal may not be used as a basis for adverse employment action. The Office of the Superintendent of Public Instruction, in consultation with the Department of Health and with input from specified stakeholders, must develop anaphylaxis policy guidelines for schools, including required training certification (on a Department of Health form to be kept on file), emergency plan and communication procedures, and allergen‑exposure reduction strategies. The bill defines “anaphylaxis” as a severe, potentially life‑threatening allergic reaction.
The text references and depends on standing order and protocol provisions in RCW 43.70.827 and RCW 28A.210.380; those provisions and the full standing order/protocol details are not included here. The bill also retains a September 1, 2009 deadline referenced in the amended statute text; the reason for retaining that historical date in this 2025 amendment is not explained in the provided excerpts.
|
|
Why it matters
Powered by Legitron |
If enacted, schools will be expected to keep a supply of epinephrine (including autoinjectors) sized to their enrollment and allow school nurses or other trained staff to use school‑owned or any available epinephrine to treat anaphylaxis on campus or during trips, even if the student does not have a personal prescription on file. Schools can accept donated epinephrine but it must have a prescription, and districts must reimburse the owner if staff use epinephrine that is not school‑owned and not owned by the person treated. The Office of the Superintendent of Public Instruction and Department of Health will produce model guidelines and a training certification form that schools must use, and staff (except certain licensed health providers) may opt out in writing from administering autoinjectors without fear of job penalty; the bill also limits liability for prescribers, pharmacists, and school employees unless they act with conscious disregard for safety.
The groups most affected are school districts and private schools (including charter and state‑tribal compact schools), school nurses and designated trained personnel, and prescribing health professionals and pharmacists. Districts will likely need to budget for buying, storing, and replacing epinephrine or for reimbursing owners, set up training and recordkeeping for certifications, and adopt policies aligned with the new guidelines; their risk of legal exposure for staff administering epinephrine is reduced. The bill leaves out the full text of the referenced standing order and protocol and retains an unexplained 2009 deadline in the amended text, so specific operational details and timing for some requirements are unclear.
|
| Official Documents | View Full Bill Text |
| Senator Wellman (Primary) |
| Senator Slatter |
| Senator Boehnke |
| Senator Hasegawa |
| Senator Nobles |
| Senator Stanford |
| Senator Trudeau |
| Senator C. Wilson |
| Hearing | Senate Early Learning & K-12 Education (Public) |
| Hearing | Senate Early Learning & K-12 Education (Executive) |
| Hearing | House Education (Public) |
| Hearing | House Education (Public) |
| Hearing | House Education (Executive) |